Vertex to Announce Second-Quarter 2020 Financial Results on July 30
2020年7月16日 - 10:00PM
ビジネスワイヤ(英語)
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report
its second-quarter 2020 financial results on Thursday, July 30,
2020 after the financial markets close. The company will host a
conference call and webcast at 5:30 p.m. ET. To access the call,
please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001
(International).
The conference call will be webcast live and a link to the
webcast can be accessed through Vertex's website at www.vrtx.com in
the "Investors" section. To ensure a timely connection, it is
recommended that participants register at least 15 minutes prior to
the scheduled webcast. An archived webcast will be available on the
company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious diseases. The company has multiple approved medicines
that treat the underlying cause of cystic fibrosis (CF) — a rare,
life-threatening genetic disease — and has several ongoing clinical
and research programs in CF. Beyond CF, Vertex has a robust
pipeline of investigational small molecule medicines in other
serious diseases where it has deep insight into causal human
biology, including pain, alpha-1 antitrypsin deficiency and
APOL1-mediated kidney diseases. In addition, Vertex has a rapidly
expanding pipeline of genetic and cell therapies for diseases such
as sickle cell disease, beta thalassemia, Duchenne muscular
dystrophy and type 1 diabetes mellitus.
Founded in 1989 in Cambridge, Mass., Vertex's global
headquarters is now located in Boston's Innovation District and its
international headquarters is in London, UK. Additionally, the
company has research and development sites and commercial offices
in North America, Europe, Australia and Latin America. Vertex is
consistently recognized as one of the industry's top places to
work, including 10 consecutive years on Science magazine's Top
Employers list and top five on the 2019 Best Employers for
Diversity list by Forbes. For company updates and to learn more
about Vertex's history of innovation, visit www.vrtx.com or follow
us on Facebook, Twitter, LinkedIn, YouTube and Instagram.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200716005153/en/
Vertex Pharmaceuticals Incorporated Investors:
Michael Partridge, 617-341-6108 Zach Barber, 617-341-6470 Brenda
Eustace, 617-341-6187
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 6 2024 まで 7 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 7 2023 まで 7 2024